Home Equities Score POAI Stock Price Plummeted By 2.63%. Here is what happened

POAI Stock Price Plummeted By 2.63%. Here is what happened

Predictive Oncology (NASDAQ: POAI), an oncology and drug discovery company with an emphasis on artificial intelligence, confirmed that its wholly-owned daughter company, TumorGenesis has established a deal with the Swedish firm Cellevate AB.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

The companies have planned to combineTumorGenesis’ medias with Cellevate’s high engineered matrix materials. The complementary nature of their businesses is anticipated to be beneficial for both companies.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

At last check-in premarket trading, shares of Predictive Oncology Inc. (POAI) were down -2.32% at $1.116. POAI’s stock closed the last session at $1.14, increasing 4.59% or $0.05. Shares of the company fluctuated between $1.02 and $1.14 throughout the day. The shares of Predictive Oncology Inc. have advanced 31.25% in the last five days; however, they have gained 5.56% over the last month.

First Quarter 2021 Financial Result

Predictive Oncology generated revenue of $280,317 for the quarter, versus $294,943 for the first quarter in the previous year. However, the company also had reduced expenses, which produced a loss per share of $0.11, in comparison to a loss of $0.93 in the prior year.

During the first quarter ended on March 31, 2021, and 2020, all revenue was produced from the Skyline Medical business apart from $1,989 and $15,130 in Helomics revenues, respectively, and $14,075 during the first quarter of 2021, in the Soluble reportable department

The gross profit margin was almost 65% in the three months completed on March 31, 2021, in comparison to 69% in 2020. The margins declined in the present year as costs were higher, which more than offset the revenue generated in the present period.

POAI’s (G&A) expenses saw a rise by $442,301 for the first quarter of 2021versus the prior year. The rise was mainly because of higher severance and share-based compensation linked with the retirement of the previous CEO, higher depreciation facilitated by recently purchased assets placed in service during the first quarter of 2021, and higher audit and related fees.

Moreover, these increases were primarily due to a decrease in expenses linked to share-based compensation for awards made in the previous year and other share-based payments as well as reduced franchise taxes.

Operations expenses surged by $26,059 to $574,812 in the first quarter of 2021 in comparison to 2020. The increase was facilitated by higher costs related to the staff and increased AI computing costs.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

Confirmation of established deal with Swedish firm Cellevate AB failed to induce adequate investor interest, with POAI stock declining immensely at last check.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

Comstock Mining Inc. (LODE) stock soar during pre-market trading. What’s happening?

Comstock Mining Inc. (NASDAQ: LODE) stock gained by 1.14% at last close while the LODE stock price surged by 3.10% in the pre-market trading...

Why MediciNova Inc (MNOV) stock facing negativity since Monday’s after-hours?

MediciNova Inc. (MNOV) shares lost 5.71% in after-hours on Monday, June 21, 2021, and the plummeting continues in the pre-market session on Tuesday as...

Tiziana Life Sciences Inc. (TLSA) stock surged during pre-market. Let’s see why?

Tiziana Life Sciences Inc. (NASDAQ: TLSA) stock declined by 2.54% at last close however the TLSA stock price depicts a rise of 8.26% during...

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (NASDAQ: HSTO) stock gained by 16.16% at last close whereas the HSTO stock price declines by 2.73% in the pre-market trading. Histogen...

Related News

Tiziana Life Sciences Inc. (TLSA) stock surged during pre-market. Let’s see why?

Tiziana Life Sciences Inc. (NASDAQ: TLSA) stock declined by 2.54% at last close however the TLSA stock price depicts a rise of 8.26% during...

Pyxis Tankers Inc. (PXS) stock fell during pre-market trading. Why so?

Pyxis Tankers Inc. (NASDAQ: PXS) stock declined by 0.06% at the last close while the PXS stock price plunged by 6.15% in the pre-market...

Globalstar Inc. (NASDAQ: GSAT) stock surged during after-hour session. Here’s the update:

Globalstar Inc. (NASDAQ: GSAT) stock gained by 23.18% at last close while the GSAT stock price rises by 4.3% in the after-hours session. Globalstar...

Millendo Therapeutics Inc. (MLND) stock plunged during after-hour session. Here’s to know why?

Millendo Therapeutics Inc. (NASDAQ: MLND) stock gained by 3.76% at the last close while the MLND stock price declines by 13.04% in the after-hours...

Bio-Path Holdings Inc. (BPTH) stock gains during current market trading. Here’s to know why?

Bio-Path Holdings Inc. (NASDAQ: BPTH) stock surged by 8.76% in the current market trading. Bio-Path is a biotech firm working on DNAbilize, a new...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

7542

GIFT

Download free eBook for 

7 GROWTH  STOCKS FOR 2021

WAIT 
WE HAVE GIFT FOR YOU

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam